Back
Edgewise Therapeutics Vs. Halozyme Therapeutics Industry Stock Comparison
Buy
72
EWTX
Edgewise Therapeutics
Last Price:
29.81
Seasonality Move:
13.73%
Sell
30
HALO
Halozyme Therapeutics
Last Price:
51.68
Seasonality Move:
20.13%
Buy
72
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $30.33. The Score for EWTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $50.65. The Score for HALO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- HALO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $30.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $50.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
EWTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.47 | Buy |
Relative Strength Index (14 RSI): | 71.49 | Buy |
Chaikin Money Flow: | 1376532 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.65 - 28.39) | Buy |
Bollinger Bands (100): | (16.13 - 23.39) | Buy |
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.4 | Sell |
Relative Strength Index (14 RSI): | 30.8 | Sell |
Chaikin Money Flow: | -1825954 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.62 - 61.32) | Sell |
Bollinger Bands (100): | (49 - 60.08) | Sell |
EWTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.85 | Buy |
20-day SMA: | 25.06 | Buy |
50-day SMA: | 20.75 | Buy |
200-day SMA: | 17.95 | Buy |
8-day EMA: | 27.95 | Buy |
20-day EMA: | 25.53 | Buy |
50-day EMA: | 22.44 | Buy |
200-day EMA: | 17.77 | Buy |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.28 | Sell |
20-day SMA: | 58.18 | Sell |
50-day SMA: | 58.64 | Sell |
200-day SMA: | 46.49 | Buy |
8-day EMA: | 55.36 | Sell |
20-day EMA: | 57.29 | Sell |
50-day EMA: | 57.37 | Sell |
200-day EMA: | 49.67 | Buy |
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.35 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $0.79 per share.
Edgewise Therapeutics Technical Analysis
Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Halozyme Therapeutics Technical Analysis
Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |